First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q1 2024 (March 31)19holders
$27.97avg. 13F price*
At the end of Q1 2024, 19 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings. The largest holders were Steward Partners Investment Advisory, LLC ($1.8M), LPL Financial LLC ($1.7M) and Goldman Sachs Group Inc. ($1.2M).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $1.5M |
| Exits | 6 | $1.3M |
Ownership 19 holders
| Steward Partners Investment Advisory, LLC | 0.02% | Add +16.2% | 63,856 | $1.8M |
| LPL Financial LLC | 0.00% | Reduce -8.6% | 61,648 | $1.7M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -28.3% | 44,564 | $1.2M |
| Janney Montgomery Scott LLC | 0.00% | New | 36,764 | $1.0M |
| Susquehanna International Group, LLP | 0.00% | Reduce -43.4% | 17,916 | $502K |
| WMG Financial Advisors, LLC | 0.25% | Reduce -9.0% | 15,539 | $435K |
| Ameritas Investment Partners, Inc. | 0.01% | Add +5.5% | 11,200 | $314K |
| Stratos Wealth Partners, LTD. | 0.00% | New | 9,183 | $257K |
| Debussy Capital Management LP | 0.07% | New | 8,539 | $229K |
| Lanark Financial, Inc. | 0.02% | Reduce -1.9% | 6,212 | $174K |
| Bank of Montreal | 0.00% | No change | 5,969 | $168K |
| Royal Bank of Canada | 0.00% | Reduce -80.9% | 4,226 | $118K |
| Osaic Holdings, Inc. | 0.00% | Reduce -17.7% | 2,348 | $66K |
| Harbour Investments, Inc. | 0.00% | No change | 836 | $23K |
| Continuum Advisory, LLC | 0.00% | New | 650 | $17K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $17K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $13K |
| IFP Advisors, Inc | 0.00% | No change | 307 | $9K |
| Morgan Stanley | 0.00% | Add +100.0% | 2 | $71 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.